AI assistant
Sending…
Compass Therapeutics, Inc. — Director's Dealing 2023
Apr 24, 2023
32588_dirs_2023-04-24_be5e55ca-a23a-47e0-b0d8-ebc89cde3086.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Compass Therapeutics, Inc. (CMPX)
CIK: 0001738021
Period of Report: 2023-04-21
Reporting Person: LINDAHL RICHARD S (Director)
More from Compass Therapeutics, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Jan 12
Regulatory Filings
2026
Jan 8
Regulatory Filings
2026
Jan 6
Director's Dealing
2026
Jan 5